Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626210 · ClinicalTrials.gov registry record · Phase 4
Modafinil Treatment for Sleep/Wake Disturbances in Older Adults
A Phase 4 study, sponsored by VA Palo Alto Health Care System.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT00626210: Clinical Trial Phase 4 study, sponsored by VA Palo Alto Health Care System.
NCT00626210 is a Phase 4 study that was terminated before completion, run by VA Palo Alto Health Care System. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00626210, a Phase 4 study, was terminated before completion, sponsored by VA Palo Alto Health Care System.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
Modafinil, trade named Provigil, is a medication approved by the Food and Drug Administration for the treatment of narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. Each of these problems is characterized by difficulty sleeping at night and excessive daytime sleepiness. Modafinil is prescribed during the day to counteract this sleepiness. The idea behind this treatment is that sleepiness that leads to napping during the day prevents a patient from being tired or sleepy enough to get good sleep at night. This study is designed to determine if the medication can "reset" participants' sleep/wake rhythm to a more normal rhythm.
Interventions
- DRUG modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Why NCT00626210 stopped before completion
NCT00626210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which modafinil is the first listed.
NCT00626210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00626210 about?
NCT00626210 is a clinical study titled "Modafinil Treatment for Sleep/Wake Disturbances in Older Adults". Modafinil, trade named Provigil, is a medication approved by the Food and Drug Administration for the treatment of narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. Each of these problems is characterized by difficulty sleeping at night and excessive daytime sleep...
What is the current status of trial NCT00626210?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2008-02. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00626210?
The interventions under investigation include: modafinil (DRUG).
Who is sponsoring clinical trial NCT00626210?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00626210's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia